Moderna to submit Covid-19 vaccine to FDA; full results show 94% efficacy
Moderna creates new role, raids Novartis for manufacturing head
Moderna Is Applying for Emergency F.D.A. Approval for Its Coronavirus Vaccine - The New York Times
Protesters at Moderna's Cambridge headquarters call for vaccine patent waivers, expanded global access - The Boston Globe
Moderna, Inc. - Home | Facebook
Moderna taps Kenya as site for $500M mRNA manufacturing facility | Fierce Pharma
exposición Fotografía moderna y contemporánea | Artnexus
Moderna on Twitter: "We just announced that the Moderna COVID-19 Vaccine retains neutralizing activity against emerging variants first identified in the U.K. and the Republic of South Africa. Read more: https://t.co/UCCvX0PrKV https://t.co/nCGl3hfhlU" /
Gavi signs agreement with Moderna to secure doses on behalf of COVAX Facility | Gavi, the Vaccine Alliance
Promising Interim Results from Clinical Trial of NIH-Moderna COVID-19 Vaccine | National Institutes of Health (NIH)
Moderna bivalent Covid vaccine appears to work against omicron subvariants BA.4 and BA.5
FDA OKs mixing COVID vaccines; backs Moderna, J&J boosters | AP News
Moderna | Partners - Official Site of the 2022 US Open Tennis Championships - A USTA Event
Moderna's Covid-19 vaccine is strongly effective, early look at data show
Moderna sues Pfizer and BioNTech over coronavirus vaccine | Massachusetts | The Guardian
Moderna says its new vaccine booster shows 'superior' response to omicron : NPR
Moderna sues Pfizer and BioNTech alleging patent infringement over Covid vaccine
U.S. FDA clears additional lots of Moderna's Covid booster amid shortage | Reuters
Moderna's COVID-19 vaccine to roll out across the US
Moderna (MRNA) Says It's Suing Pfizer (PFE), BioNTech Over Covid Shots - Bloomberg
Moderna says its vaccine for ages under 6 will be ready for U.S. review in June | Reuters
Mundo propio Fotografía moderna argentina 1927-1962 Malba
US opens second COVID boosters to 50 and up, others at risk | AP News
NIH's Fight for Ownership of Moderna's COVID-19 Patent Highlights Hazards of Business Collaborations
